Trice Medical Receives FDA 510(k) Clearance for mi-eye 2
Trice Medical received FDA 510(k) clearance to market mi-eye 2, a disposable needle with integrated camera to support diagnosis of joint injury.
The next-generation iteration of mi-eye technology is designed for use in diagnostic and operative arthroscopic and endoscopic procedures to illuminate an interior cavity through a natural or surgical opening. mi-eye 2 also allows injection or aspiration under direct visualization.
Platform enhancements include improved resolution, field of view, depth of field and overall visualization.
Sources: Trice Medical; ORTHOWORLD Inc.